2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Epilepsy, Absence: new trials by email Literature Review of Epilepsy, Absence trials Research Report on Epilepsy, Absence
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures NPT 2042, Placebo - Epilepsy, Generalized, Epilepsy, Absence | Phase 2 | Completed | NeuroPro Therapeutics, Inc. | 14 | 2025-03-11 | 2026-09-28 |
| A Pilot Study of Topiramate in Childhood Absence Epilepsy topiramate - Epilepsy, Absence | Phase 2 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 12 | 2005-03-01 | 2011-06-10 |
Epilepsy (1) · Epilepsy, Generalized (1) · Seizures (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Epileptic Syndromes (2) · Nervous System Diseases (2) · Epilepsy (1) · Epilepsy, Generalized (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Topiramate (1)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1) · NeuroPro Therapeutics, Inc. (1)
United States (1)